Scienture Holdings, Inc. (Nasdaq: SCNX) announced a securities purchase agreement with institutional investors.
3,225,000 shares of common stock will be purchased at $1.20 per share in a registered direct offering, expecting gross proceeds of approximately $3.9 million.
Offering to close on August 15, 2025, subject to customary closing conditions.
Offering Details
3,225,000 shares of common stock to be sold at $1.20 per share.
Gross Proceeds
Expected to be approximately $3.9 million before expenses.
Placement Agent
Maxim Group LLC is the sole placement agent.
- The offering is made through an effective shelf registration statement on Form S-3.
- Maxim Group LLC is facilitating the offering, ensuring compliance with SEC regulations.
Scienture Holdings continues to focus on enhancing value for patients and physicians through specialty pharmaceutical products.